Install the app
How to install the app on iOS

Follow along with the video below to see how to install our site as a web app on your home screen.

Note: This feature may not be available in some browsers.


Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

E

EGBOT

Guest
Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

HTML:
Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

Source: Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Latest threads

Back
Top